C Kent Osborne

5PUBLICATIONS
122CO-AUTHORS
BiomaterialsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 22, 2026
Rat somatic genome editing enables ER+ breast cancer modeling.

|Aug 08, 2025
Integrative Proteogenomics and Forward Genetics Reveal a Novel Mitotic Vulnerability in Triple-Negative Breast Cancer.

Nicholas J Neill, Shankha Satpathy, Karsten Krug

|May 17, 2023
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.

Jamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis

|Jan 30, 2023
Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis.

Grazia Arpino, Juan de la Haba Rodríguez, Jean-Marc Ferrero

|Aug 24, 2022
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.

Meenakshi Anurag, Eric J Jaehnig, Karsten Krug

Pageof 1